Associated Papers
Distinct tau filament folds in familial frontotemporal dementia due to the MAPT S305I mutation.
Pan HS et al.
Biorxiv : the Preprint Server for Biology, 2026
Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.
Sampognaro PJ et al.
Molecular Neurodegeneration, 2023
37131250 (PubMed )
Supplement: 13024_2023_621_MOESM1_ESM.pdf
Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration.
Chen Q et al.
Frontiers in Neurology, 2020
FTD spectrum: Neuroimaging across the FTD spectrum.
Whitwell JL
Progress in Molecular Biology and Translational Science, 2019
In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.
Jones DT et al.
Neurology, 2018
Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.
Markopoulou K et al.
Plos One, 2016
Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI.
Lunau L et al.
Bmj Open, 2012
MAPT S305I mutation: implications for argyrophilic grain disease.
Kovacs GG et al.
Acta Neuropathologica, 2008
Select a paper to view details